Pyxis Oncology Inc (PYXS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $188.98M
Last updated: Nov 17, 2026 at 11:05 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 38.0% below its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 29.0, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about PYXS
News
PYXS Valuation
PYXS Profitability: Margins, ROIC and FCF
Pyxis Oncology (PYXS) has an operating margin of -792.0% and a net margin of 0.0%. It posts a -697.1% FCF margin.
- Operating margin
- -792.0%
- Net margin
- 0.0%
- ROE
- -157.5%
- FCF margin
- -697.1%
Pyxis Oncology Competitors
The companies most similar to Pyxis Oncology (PYXS) include Compass Therapeutics, PolyPid and Innate Pharma.
Sector: Healthcare
Companies most similar to Pyxis OncologyPYXS Analyst Ratings
Pyxis Oncology (PYXS) has a Buy consensus from 10 analysts: 9 Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell.
- Consensus
- Buy
- Analysts
- 10
- Strong Buy
- 1
- Buy
- 8
- Hold
- 1
- Sell
- 0
- Strong Sell
- 0
PYXS Bull Case vs Bear Case
Bull case
- 90.0% of PYXS's analyst ratings are Buy or Strong Buy.
Bear case
- PYXS beat EPS estimates in 37.5% of its last 8 reported quarters.
PYXS Earnings: Beat Rate and Next Report
Pyxis Oncology (PYXS) beat the EPS estimate in 3 of the last 8 quarters (37.5%). Its next report is expected on Mar 22, 2027.
- Beat rate
- 3 of 8 quarters (37.5%)
- Average surprise
- -40.3%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.23
PYXS Earnings Date
PYXS reports Mar 22, 2027. The date is estimated.
PYXS ETF Holders
GNG tracks 2 ETFs that hold PYXS. The largest weights:
- iShares Biotechnology ETF (IBB), 0.01% of the fund
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
Updated Nov 5, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About PYXS
When does PYXS report earnings?
Pyxis Oncology Inc (PYXS) is expected to report earnings on Mar 22, 2027.
Does PYXS pay dividends?
Pyxis Oncology Inc (PYXS) does not currently pay a regular dividend.
What is PYXS's market cap?
Pyxis Oncology Inc (PYXS) has a market capitalization of $188.98M with a current stock price of $1.41.
PYXS pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.